An imbalance in insulin signaling can drive metabolic disease due to its activity as a regulator of cellular metabolic homeostasis [31] and our unbiased proteomic analyses further revealed significant changes in key downstream mediators of the transcriptional response to insulin signaling that are central to metabolic homeostasis. This evidence concerns the gene INS and Other metabolic disease.